BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7889189)

  • 1. Angiotensin II Receptor Antagonists: Can they Go Beyond ACE Inhibitors? Proceedings of a satellite symposium to the 15th scientific meeting of the International Society of Hypertension. Melbourne, Australia, March 1994.
    Blood Press Suppl; 1994; 5():1-133. PubMed ID: 7889189
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin receptor antagonists.
    Wong W; Howes L
    Aust Fam Physician; 2000 Jul; 29(7):653-5, 658. PubMed ID: 10914449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy for prehypertension--mission accomplished?
    Schunkert H
    N Engl J Med; 2006 Apr; 354(16):1742-4. PubMed ID: 16537661
    [No Abstract]   [Full Text] [Related]  

  • 4. Angiotensin receptor antagonists.
    Goldsmith DJ
    Lancet; 1997 Apr; 349(9060):1255. PubMed ID: 9130973
    [No Abstract]   [Full Text] [Related]  

  • 5. Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites.
    Schmidt B; Schieffer B
    J Med Chem; 2003 Jun; 46(12):2261-70. PubMed ID: 12773029
    [No Abstract]   [Full Text] [Related]  

  • 6. Antihypertensive effects of candesartan cilexetil, enalapril and placebo.
    Franke H
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S61-2. PubMed ID: 9331010
    [No Abstract]   [Full Text] [Related]  

  • 7. [The medicine of the month. Losartan (Cozaar)].
    Scheen AJ
    Rev Med Liege; 1997 May; 52(5):367-9. PubMed ID: 9273640
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical profiles of new angiotensin II receptor blockers: telmisartan, olmesartan medoxomil, and irbesartan].
    Ishii M
    Nihon Rinsho; 2004 Jan; 62(1):193-202. PubMed ID: 14737853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candesartan cilexetil and enalapril are of equivalent efficacy in patients with mild to moderate hypertension.
    Zanchetti A; Omboni S; Di Biagio C
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S57-9. PubMed ID: 9331009
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of the antihypertensive effects of candesartan cilexetil and losartan in patients with mild to moderate hypertension.
    Andersson OK; Neldam S
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S63-4. PubMed ID: 9331011
    [No Abstract]   [Full Text] [Related]  

  • 11. Possible benefits of azilsartan compared with other angiotensin II type 1 receptor blockers.
    Miura S; Saku K
    Hypertens Res; 2014 Sep; 37(9):799-800. PubMed ID: 25007763
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiotensin II receptor antagonists in the treatment of hypertension.
    Kaplan NM
    Am Fam Physician; 1999 Sep; 60(4):1185-90. PubMed ID: 10507747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-acting blood pressure reduction by candesartan cilexetil in patients with hypertension.
    Bönner G; Fuchs W
    Curr Med Res Opin; 2005 Jun; 21(6):935-40. PubMed ID: 15969893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fast-acting sartan. High blood pressure therapy without long waiting time].
    MMW Fortschr Med; 2003 Jun; 145(24):55. PubMed ID: 12866306
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of the renin-angiotensin system in hypertension in the elderly.
    Nagano M; Higaki J; Mikami H; Ogihara T
    Blood Press Suppl; 1994; 5():130-3. PubMed ID: 7889195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-four hour blood pressure profile of different doses of candesartan cilexetil in patients with mild to moderate hypertension.
    Heuer HJ; Schöndorfer G; Högemann AM
    J Hum Hypertens; 1997 Sep; 11 Suppl 2():S55-6. PubMed ID: 9331008
    [No Abstract]   [Full Text] [Related]  

  • 17. Losartan: the first angiotensin receptor antagonist in clinical use.
    Beevers DG
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S1. PubMed ID: 8583475
    [No Abstract]   [Full Text] [Related]  

  • 18. [Irbesartan--a new AT1-receptor antagonist (AT1-blocker). Angiotensin-II-receptor antagonists: perspectives of a new therapeutic principle, Wiesbaden, 6 April 1997].
    Dtsch Med Wochenschr; 1997 Sep; 122(37 Suppl):1-4. PubMed ID: 9330579
    [No Abstract]   [Full Text] [Related]  

  • 19. [Organ protection by angiotensin II receptor blockers].
    Kumagai H; Onami T; Takimoto C; Iigaya K; Saruta T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():569-73. PubMed ID: 15171437
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dosage equivalents of AT1-receptor antagonists available in Germany].
    Dominiak P; Häuser W
    Dtsch Med Wochenschr; 2003 Oct; 128(44):2315-8. PubMed ID: 14593575
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.